News

Constituent stock Pyxis Oncology closed up 24.22%, with Humacyte, ATAI Beckley, Moderna, Immunitybio Inc., GH Research, and Abcellera Biologics rising between 18.05% and 10.81%. Compass Pathways followed closely with a 9.20% increase. On the downside, Kymera closed down 7.26%, ranking fourth from the bottom, Ardelyx dropped 8.50%, Mesoblast fell 9.03%, and Omeros Corporation (OMER) plunged 19.17%.

This major policy shift aims to restore macroeconomic stability. In a decree, the Bolivian Ministry of Economy stated that the transition will be supervised by the Central Bank of Bolivia, and the government's goal is to "strengthen macroeconomic stability, maintain external competitiveness, and promote balance of international payments." Expand

Jinse Finance reported on June 27 that as the price of SOL rose by about 9% on Friday, shares of multiple Solana digital asset treasury companies also surged significantly. Sol Strategies jumped as much as 22% intraday, reaching $1.20 and outperforming other crypto treasury stocks. Other Solana digital asset treasury companies also recorded notable gains. Forward Industries rose as much as 12% intraday to $4.03, SkyAI climbed 11% to $1.07, DeFi Development Corp. gained 10% to $2.73, and Solana Company also increased by over 10%, hitting a high of $1.65. This rally was further driven by expectations of inclusion in indices. Several digital asset treasury companies, including Forward, the largest Solana treasury company, will be included in the Russell Index after the market closes on Friday. Two major Ethereum treasury companies, Bitmine and SharpLink, will also be included in the relevant Russell Index, while the smaller Solana treasury company Upexi will join the Russell Microcap.